This topic contains a solution. Click here to go to the answer

Author Question: The best way to reduce nonsampling errors is to: a. increase sample size. b. improve data ... (Read 165 times)

Themember4

  • Hero Member
  • *****
  • Posts: 538
The best way to reduce nonsampling errors is to:
 a. increase sample size.
  b. improve data collection techniques.
  c. offer incentives to respondents.
  d. substitute the next house on the block for not-at-homes.
  e. Nonsampling errors cannot be reduced.

Question 2

Which of the following is FALSE?
 a. It is not difficult to estimate the size and effects of nonsampling errors.
  b. Reduction of nonsampling error depends on improving method.
  c. Nonsampling errors are not as manageable as sampling errors.
  d. Nonsampling errors arise from weaknesses in research procedure. They are likely to increase with increases in the sample size.
  e. Nonsampling errors contribute more than sampling errors to total error in most surveys.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

lcapri7

  • Sr. Member
  • ****
  • Posts: 350
Answer to Question 1

B

Answer to Question 2

A





 

Did you know?

About 3.2 billion people, nearly half the world population, are at risk for malaria. In 2015, there are about 214 million malaria cases and an estimated 438,000 malaria deaths.

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

More than one-third of adult Americans are obese. Diseases that kill the largest number of people annually, such as heart disease, cancer, diabetes, stroke, and hypertension, can be attributed to diet.

Did you know?

About 3% of all pregnant women will give birth to twins, which is an increase in rate of nearly 60% since the early 1980s.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library